To elucidate the structural basis of T cell recognition of hapten-modified antigenic peptides, we studied the interaction of the T1 T cell antigen receptor (TCR) with its ligand, the H-2K 
CD8
ϩ cytotoxic T lymphocytes (CTL) 1 recognize by means of their T cell antigen receptor (TCR) antigenic peptides, usually 8 -10 amino acids long, bound to major histocompatibility complex (MHC) class I molecules on target cells (1) (2) (3) (4) . However, CD8 ϩ (and CD4 ϩ ) T cells can also recognize antigenic peptides containing nonpeptidic moieties, such as carbohydrates or haptens, like trinitrophenyl, azobenzenearsonate, fluorescein, or phenylazides (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . Such T cells can be readily elicited and play a role in diseases, e.g. allergies, contact dermatitis, and eczema (16) . The recognition of modified peptides is highly specific, and even small changes in the hapten or carbohydrate moiety can dramatically affect antigen recognition (13) (14) (15) (16) (17) (18) . This is reminiscent of immunoglobulins, which can be raised against and specifically bind such structures (19, 20) . While x-ray crystallographic studies have revealed how antibodies bind haptens, little is known about how TCR do this. This is of particular interest, because TCR genes, unlike immunoglobulin genes, have no somatic mutations allowing affinity maturation. Moreover, TCR need to recognize hapten or carbohydrate moieties in the context of an MHC-peptide complex in a predefined orientation (21) (22) (23) (24) (25) .
Available three-dimensional structures of TCR-ligand complexes revealed a consensus "diagonal" TCR-ligand orientation, in which the MHC-bound peptide runs diagonally between the CDR3 loops, extending from CDR1␣ to CDR1␤ (21, (23) (24) (25) . In this orientation, the CDR3 loops can interact extensively with peptide side chains, which are mainly located in the center of MHC molecules, as well as with residues of the MHC ␣-helices. The ␣-helices of MHC class I molecules are elevated at the N-terminal portions; therefore, the approximately planar surface of the TCR ligand binding site can realize the best contact with the ligand in a diagonal orientation (21) .
Hapten or carbohydrates conjugated with antigenic peptides are part of the epitope recognized by TCR (5, 8 -15) . TCR specific for hapten-modified antigenic peptides typically exhibit preferential usage of certain V␤/J␣, and/or specific junctional sequences (13, 15, 18) . We used as hapten photoreactive 4-azidobenzoic acid (ABA). This allowed assessment of TCRligand binding by TCR photoaffinity labeling and identification of the photoaffinity-labeled site(s), i.e. the contact(s) of the hapten with the TCR (13, 15) .
We have previously generated and characterized two families of H-2K d -restricted CTL clones, specific for two different photoreactive derivatives of the Plasmodium berghei circumsporozoite peptide PbCS-(252-260) (SYIPSAEKI) (13, 15) . In one peptide derivative, ABA was conjugated with PbCS Lys 259 , whereas P-255 was replaced by Lys(ABA) in the other. In addition, to prevent K d -peptide derivative complex dissociation, PbCS Ser 252 was replaced with iodo-4-azidosalicylic acid (IASA), which upon selective photoactivation permitted covalent attachment of the peptide derivative to K d (26) . The ABA, but not the IASA group, was part of the epitope recognized by these CTL. The two families of CTL clones were non-crossreactive, and exhibited different TCR sequences (13, 15) .
In this study, we describe the interaction of the TCR of the T1 CTL clones with its ligand, K d -bound IASA-YIPSAEK-(ABA)I. Using mutational analysis, mapping of the photoaffinity-labeled site(s) and molecular modeling, we identified a specific binding mode, how the T1 TCR binds the ABA group. We propose that this binding principle has universal aspects.
EXPERIMENTAL PROCEDURES
Peptide and Peptide Derivative Synthesis-Amino acids and other chemicals were obtained from Bachem Finechemicals AG (Bubendorf, Switzerland), Sigma Chemie (Buchs, Switzerland), and Neosystems (Strasbourg, France). Synthesis and characterization of peptide derivatives was performed as described previously (15, 17, 26) . HPLC-purified peptide derivatives were reconstituted in PBS at 1 mM. The specific radioactivity of 125 I conjugates was approximately 2000 Ci/mmol. Cellular Assays-For the cytolytic assay, 51 Cr-labeled P815 cells (5 ϫ 10 3 cells/well) were incubated for 1 h at 37°C in medium containing 10-fold dilutions of peptide derivatives, followed by UV irradiation at Ն350 nm. Cloned T1 CTL (1.5 ϫ 10 4 cells/well) were added, and after 4 h of incubation at 37°C, released 51 Cr was determined. The specific lysis was calculated as 100 ϫ ((experimental Ϫ spontaneous release)/ (total Ϫ spontaneous release)). The relative antigenic activities were calculated by dividing the concentration of IASA-YIPSAEK(ABA)I required for half-maximal lysis by that required for the variant peptide derivatives. These values were normalized by division with the corresponding relative K d competitor activities (14, 15, 17) . K d and TCR Photoaffinity Labeling-All photoaffinity labeling procedures were performed as described previously (15, 17) . In brief, for TCR photoaffinity labeling, 10 7 cpm of K d -125 IASA-YIPSAEK(ABA)I were incubated with 10 7 T1 CTL on ice for 3 h, followed by UV irradiation at 312 Ϯ 40 nm. For peptide mapping, T1 CTL (4 ϫ 10 7 ) were incubated likewise with K d -SYIPSAEK( 125 IASA)I (1 mCi) in 2 ml of medium containing ␤ 2 -microglobulin (2.5 g/ml). After UV irradiation at Ն350 nm, cells were washed twice and lysed in phosphate-buffered saline (1 ϫ 10 7 cells/ml) containing 0.7% Nonidet P-40, HEPES, phenylmethylsulfonyl fluoride, leupeptin, and iodoacetamide. The detergent-soluble fractions were subjected to immunoprecipitation with anti-TCR C␤ monoclonal antibody H57-597. The immunoprecipitates were analyzed by SDS-PAGE (10%, reducing conditions) and quantified using a PhosphorImager and the ImageQuant software (Molecular Dynamics, Inc., Sunnyvale, CA). S.D. values were calculated from 2-4 experiments.
Soluble T1 TCR and Mutants-T1 ␣ and ␤ cDNAs extending from the 5Ј terminus up to, but not including, bases encoding the extracellular membrane-proximal cysteine residues were generated by reverse transcription on total T1 CTL RNA followed by polymerase chain reaction (PCR) amplification. The DNA fragments encoding a linker sequence and leucine zipper (LZ) components were generated by using oligonucleotides and PCR on templates pACID and pBASE (27) . The T1 TCRleucine zipper cDNAs were prepared by using recombinant PCR on these templates. The T1␣LZ and T1␤LZ cDNA containing basic and acidic LZ, respectively, were cloned into pCR-script (Stratagene) and subcloned into the EcoRI site of the mammalian expression vector pCI-neo (Promega). All PCR amplifications were performed using Pfu DNA polymerase (Stratagene), and both strands of cloned inserts were sequenced and found to be error-free. TCR mutants were generated using the QuickChange site-directed mutagenesis kit (Stratagene) following the suppliers instructions. 293T cells (ATCC) were transfected with pT1␣LZ and pT1␤LZ DNA (1:2 ratio) for transient expression of soluble ␣␤T1 TCR following published procedures (28) . After 2 days, supernatants were harvested, and T1 TCR concentrations were equalized. Preparation of T1 single chain Fv cDNA constructs and protein expression were performed as described previously (29) . gested with HindIII and XbaI in order to excise the sequences encoding the cytoplasmic and transmembrane domains up to nucleotide 966. The vector was religated using a HindIII-XbaI linker containing a stop codon, giving rise to translated C terminus RWKLA-stop. This K d cDNA was cloned into the pcDNA3 expression vector (Invitrogen) under control of the cytomegalovirus promoter. Site-directed mutagenesis was performed using the Transformer TM kit (CLONTECH) according to the manufacturer's instructions. Full-length cDNA coding for ␤2m was prepared and inserted in the same vector using the proper linkers (30) .
Peptide Mapping-All procedures have been described previously (13, 15) . Enzymes were obtained from Boehringer Mannheim (Rotkreuz, Switzerland) and used as recommended (31) . In brief, photoaffinity-labeled T1 TCR was reduced, alkylated, and reconstituted in 500 l of 100 mM Tris, pH 8.0 (for tryptic digests) or 100 mM phosphate buffer, pH 7.8 (for V8 digests) containing 10% acetonitrile. Aliquots of enzymes (10 g) were added in 12-h intervals, and after 48 h of incubation at 37°C, the digests were subjected to reverse phase HPLC on an analytical C-18 column (4 ϫ 250 mm, 5-m particle size, Vydac, Hisperia, CA). The column was eluted with a linear gradient of acetonitrile in 0.1% trifluoroacetic acid, rising within 1 h from 0 to 75%. Elution of radioactivity was monitored by ␥-counting of 1-ml fractions. For destructive digestion the double-labeled V8 and Asp-N digest fragment was reconstituted in 300 l of citrate buffer (50 mM, pH 5.5) containing 50 mM NaCl and Nonidet P-40 (0.01%) and incubated at 37°C for 36 h with cathepsin C and carboxypeptidases P. Enzymes (5 g) were added every 12 h. For biosynthetic labeling of T1 TCR with [ 3 H]tyrosine, CD8 ␣/␤-transfected T1.4 T cell hybridomas (0.7 ϫ 10 6 ) were incubated in tyrosine-deficient Dulbecco's modified Eagle's medium supplemented with fetal calf serum (5%) and 5 mCi of . The related sequences of corresponding chains were aligned using a dynamic programming method implemented in the MODELLER program (33) . An all atom model of the complex was built using MODELLER by satisfaction of spatial restraints obtained from the alignment and parameters in the program. A distance restraint was introduced initially between the phenyl rings of ABA and ␤-Tyr 48 and ␤-Tyr 50 , respectively. Side chain orientations were optimized using a backbone-dependent rotamer library (36, 37) . CDR1␤ and CDR2␤ loops were not subsequently refined, since their conformation was modeled from the TCR 2C, which has the same V␤8.2 as TCR T1. For the other CDR loops, the conformations with the low energies were identified by simulated annealing with the rest of the structure fixed. From these, the final loop orientations were selected by using data from the mutation experiments. The resulting structure was refined with 500 steps of steepest descent energy minimization using the CHARMM (version 25) program (38) with the all-atom PARAM 22 parameter set (39) . No significant violation of spatial restraints was found for ␤-Tyr 48 , ␤-Tyr 50 , and K(ABA) after optimization, indicating that the imposed distance restraint does not imply a distortion of the structure. Details concerning the modeling will be presented separately. 2 1A) . The replacement of PbCS Pro 255 by Ala, Asp, or Ser reduced T1 TCR labeling by 10-, 100-, and 17-fold, respectively, whereas replacement by Leu increased it 2-fold, suggesting that voluminous aliphatic residues in this position stabilize, and polar ones destabilize, T1 TCR-ligand binding. To define the interaction of ABA with T1 TCR, PbCS(ABA) variants with modified ABA were examined. These nonphotoreactive compounds were assessed in a cytolytic assay as derivatives of SYIPSAEK(ABA)I (Fig. 1B) . Cloned T1 CTL killed target cells sensitized with SYIPSAEK(benzoic acid)I approximately 100-fold less efficiently than those sensitized with SY-IPSAEK(ABA)I. Replacement of the phenylazide by a methyl group (SYIPSAEK(Ac)I) obliterated detectable antigen recognition, while introduction of an iodine and hydroxy substituent in ABA (YIPSAEK(IASA)I) reduced the efficiency of antigen recognition by 8-fold. These results indicate that the phenylazide of the ABA moiety was essential for antigen recognition and that changes of substituents predictably affected the efficiency of recognition.
RESULTS

Effect of PbCS Peptide Derivative Mutations on T1 TCR-
Effect (Fig. 3) . Seven of these mutations reduced TCR photoaffinity labeling by Ն90%. Three of these were in CDR3 loops, three others were in CDR1, and one was in CDR2␣. In addition, six other mutations reduced T1 TCR photoaffinity labeling by Ն50%. Four of these were in CDR2␣, one was in CDR2␤, and one was in CDR3␣. Several mutations increased TCR photoaffinity labeling by up to 60% (e.g. ␣N27A, ␤Y50F, and ␤T55A). Mutants labeled with an asterisk were T1 TCR Fv single chain constructs (29) .
Localization of the Photoaffinity-labeled Site(s) on T1 TCR-To localize the photoaffinity-labeled site(s), T1 TCR was 2 O. Michielin and M. Karplus, manuscript in preparation. photoaffinity-labeled with SYIPSAEK( 125 IASA)I, a derivative that was efficiently recognized by T1 CTL (Fig. 1B) and, being monovalent, precluded cross-linking with K d . Since T1 TCR was photoaffinity-labeled exclusively at the ␤-chain (15), the photoaffinity-labeled TCR was directly subjected to peptide mapping. After extensive digestion with trypsin, the resulting digest fragments were separated by reverse phase HPLC. The major labeled digest fragment eluted from the C-18 column after 30 min and according to SDS-PAGE was homogenous and had an apparent M r of approximately 3000 (Fig. 4, lane 2) . When protease V8 was used instead of trypsin, a major labeled material eluted from the column after 32-33 min, which migrated on SDS-PAGE with an apparent M r of approximately 8300 (Fig. 4, lane 1) . The size of this fragment was bigger than any theoretical V8 fragment of the variable domain of the T1 TCR ␤-chain (Fig. 5B) , suggesting that protease V8, even after extensive digestion, omitted a cleavage site. Since this enzyme primarily cleaves C-terminal to Glu and hence may fail to cleave after Asp (31), the labeled V8 digest product was digested with protease Asp-N. Essentially the same HPLC profile was observed; however, on SDS-PAGE this material migrated with an apparent M r of approximately 2000 (Fig. 4, lane 3) , indicating that V8 failed to cleave at an aspartic acid. This residue probably was ␤-Asp 38 , because the big reduction in size (approximately 6300 Da) may correspond to the size of the segment 2-37, which contains the glycosylation site ␤-Asn
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( Fig. 5B and Ref. 34) . Accordingly, the labeled V-8 digest fragment would be 2-56 (Fig. 5B) .
To verify this, it was treated with CNBr, which cleaves at methionine residues. This resulted in the formation of a new labeled fragment, which eluted from the C18 column after 34 -35 min and migrated on SDS-PAGE with an apparent M r of approximately 2500 Da (Fig. 4, lane 4) . Since the variable domain of the T1 TCR ␤-chain contains only one methionine, this confirmed that the labeled V-8 digest fragment consisted of residues 2-56 (Fig. 5B) . The observed shift in M r suggested that the labeled site(s) was located C-terminal to ␤-Met 32 , i.e. in the segment 33-56. Moreover, the predicted labeled V8 
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). To assess their presence, it was partially digested (6 h) with Arg-C. As assessed by HPLC, this treatment produced earlier eluting radioactive materials, probably of mixed composition, as suggested by the broad range of elution (29 -31 min) . SDS-PAGE analysis of fractions 29 -31 showed three new labeled species, migrating with apparent M r of approximately 1800, 2600, and 7000, respectively, with the smaller ones eluting earlier from the HPLC column (Fig. 4, lanes 5-7) . Upon extensive digestion with Arg-C, only the smallest fragment was observed (data not shown). These findings confirm that the labeled primary V8 digest fragment was residues 2-56 and suggest that the labeled site was contained in the segment 45-56.
To substantiate this, we tested whether the labeled digest fragment resulting after digestion with V8 and Asp-N contained an arginine, by extensively digesting it with Arg-C. This treatment resulted in a new labeled fragment that according to HPLC and SDS-PAGE was indistinguishable from the smallest fragment obtained after digestion of the labeled V8 digest fragment with Arg-C (Fig. 4, lane 8) . By contrast, no change was observed when protease Lys-C was used (data not shown).
Together, these findings demonstrate that the photoaffinitylabeled site(s) was contained in the uncharged sequence 45-56 (LIHYSYGAGSTE). (Fig. 6A) . The 125 I-labeled material was extensively digested with cathepsin C and carboxypeptidase P. HPLC showed that the major 125 I-labeled material also contained 3 H (Fig. 6B) . On SDS-PAGE, this material migrated at the gel front, i.e. had a M r of less than 1000 -1200, confirming extensive, probably complete degradation (data not shown). Tyrosine and monoiodotyrosine eluted from the HPLC column in fractions 6, 7, and 19, respectively, i.e. both earlier than the double-labeled digest fragment (Fig. 6C) . These results indicate that the T1 TCR ␤-chain was photoaffinity-labeled at tyrosine residue(s) and demonstrate that this tyrosine modification was not a UV irradiation mediated trans-iodination. Table I for atom labels); the C␣ of ␣-Asn 97 makes a van der Waals contact with its CE2; OD1 of ␤-Asn 31 makes a polar interaction of the C-H . . . X type with its CD1 and CE1 and OE1 of ␤-Glu 95 with its NZ (Table I) . There is also a weak hydrogen bond between the OH group of ␤-Tyr 50 and ABA CE2 as well as a polar contact between the OH group of ␤-Tyr 48 and N2 of ABA. Finally, there is a hydrogen bond between NH1 and NH2 of ␣-Arg 99 and N3 of ABA. These interactions are consistent with the data from the mutational analysis (Figs. 1-3 (Fig. 7A) form hydrogen bonds with T1 TCR (Table I) . Alanine substitution of the underlined residues significantly reduced T1 TCR photoaffinity labeling (Fig. 2) . The predicted contacts with K d Glu 58 and Ala 158 are in accordance with TCR mutational analysis (Fig. 3) . TCR-MHC contacts 1, 6, and 7 (Table I) were also observed in the A6 TCR-HLA-A2-Tax complex (21) , and the contacts 2-4 and 6 were observed in the 2C TCR-K b -dEV8 complex (23) . According to the model, the PbCS residues Pro 255 , Ser 256 , Glu 258 , and Lys
T1 TCR Photoaffinity Labeling Involved Tyrosine Residues-
Model of the T1 TCR-K d -SYIPSAEK(ABA)I Complex-To
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(ABA) interact with T1 TCR (Table I) . Indeed, mutation of these residues, especially of Glu 258 and Lys 259 (ABA), substantially impaired T1 TCR photoaffinity labeling or antigen recognition by T1 CTL (Fig. 1) . For Pro 255 , the model shows that the upper part of the nonpolar proline ring makes a van der Waals contact with the methylene group of ␣-Gly 95 and a hydrogen bond with O of ␣-Arg
94
, which is consistent with the observation that replacement of Pro 255 with Ala, Ser, Asn, or Asp decreased T1 TCR photoaffinity labeling (Fig. 1) . For PbCS Ser 256 , the model predicts a hydrogen bond between its OH group and OD1 of ␣N96, and for PbCS Glu . Alanine substitution of ␤-Gln 97 dramatically reduced T1 TCR photoaffinity labeling (Fig. 3) and of K d Lys 146 peptide binding to K d (data not shown), since this residue also interacts with the C-terminal carboxyl group of the peptide (3, 4) .
DISCUSSION
The present study uses peptide mapping, mutational analysis, and molecular modeling to describe in structural terms how TCR can avidly and specifically bind a hapten-modified peptide in the context of a MHC class I molecule. The hapten, photoreactive ABA, conjugated at the penultimate residue of the PbCS peptide SYIPSAEKI, constituted an essential part of the epitope recognized by T1 CTL (Figs. 1 and 2) . The fact that peptide mapping allowed localization of the photoaffinity-labeled site(s) on T1 TCR (Figs. 4 and 6) indicates that this labeling was site-specific. In view of the high chemical reactivity of the radicals produced by UV irradiation (14, 15) of phenylazides and the flexible nature of the lysine side chain, this implies that the ABA group associated with the T1 TCR in a well defined orientation. If this were not so, heterogeneous photo-cross-linking would occur to preclude reproducible and resolved peptide mapping (40) . To better understand in structural terms the interaction of the photoreactive ligand side chain with the T1 TCR, we modeled the T1 TCR-K d -SIPSAEK(ABA)I complex. While available crystal coordinates of related TCR and MHC class I molecules permitted homology modeling of most of the system with good accuracy, the main problems concerned the docking the TCR to the ligand and the positioning of certain CDR loops. The docking was based on the diagonal orientation observed for all TCR-ligand complexes whose three-dimensional structures have been elucidated (21, (23) (24) (25) . This orientation involves conserved TCR-MHC class I contacts, mainly between TCR V␣ and residues of the MHC ␣1 and ␣2 helices (21, 23, 24) . Our model is in accordance with these contacts. Moreover, we made use of the interaction of ABA with ␤-Tyr 48 and ␤-Tyr 50 , as indicated by the observations that (i) the T1 TCR was photoaffinity-labeled at tyrosines of the CDR2␤ segment 45-56 (LI-HYSYGAGSTE) (Figs. 4 and 6) ; (ii) TCR of the same specificity, which expressed ␤-Tyr 48 , but not ␤-Tyr
50
, were photoaffinitylabeled also at the ␣-chain (15); (iii) ABA and IASA have low affinities for Tyr and Trp (14) ; and (iv) TCR-ligand binding, as assessed by inhibition of T1 TCR photoaffinity labeling by the soluble Fv T1 TCR, correlated with TCR photoaffinity labeling, except for the mutants ␤Y48F and ␤Y50F. According to the model, ABA inserts between the side chains of ␤-Tyr 48 and ␤-Tyr 50 , which are part of a pocket between CDR2␤ and CDR3␣ (Fig. 7) . This position is energetically favorable and provides extensive -interactions and hydrogen bond formation (Table I ). The ABA group was placed initially with a constraining potential between these tyrosine side chains, but it moved very little in subsequent energy minimization. The model shows that nine contacts, involving seven different TCR residues, further stabilize the interaction of the Lys(ABA) side chain with T1 TCR (Table I) . This is a consequence of a specific three-dimensional arrangement of CDR3␣, CDR3␤, CDR2␤, and CDR1␤ residues around the Lys(ABA) side chain. Mutation of these TCR residues, as well as modification of the Lys(ABA) side chain significantly affected T1 TCR photoaffinity labeling and antigen recognition by T1 CTL (Figs.  1 and 3) . Similarly, TCR specific for peptides conjugated with benzoarsonate or fluorescein also utilize residues from different CDR loops for hapten binding (6, 41) .
While our model is in good agreement with most of the mutational data, it failed to account for the effects of three TCR mutations (␣V49A, ␣T50A, and ␤E56A) (Fig. 3 and Table I ). Possible explanations include the following. (i) Certain mutations may result in conformational changes of CDR loops (e.g. the side chain of ␣-Val 49 is in the center of CDR2␣ and forms various contacts with the peptide backbone; therefore, the ␣V49A mutation probably affects the CDR2␣ loop conformation).
(ii) Some mutations may affect intramolecular amino acid interactions, resulting in reorientation of side chains engaged in TCR-ligand contacts (e.g. ␤-Glu 56 forms a hydrogen bond with ␣-Arg 99 , which interacts with N3 of ABA; thus, the ␤E56A mutation may be explained by reorientation of the ␣-Arg 99 side chain). (iii) Water was not included in the model, which may account for some of these divergences.
Interestingly, the majority of CTL clones obtained from mice immunized with IASA-YIPSAEK(ABA)I expressed V␤1-and J␣TA28-encoded TCR, which were photoaffinity-labeled at both chains (15) . For one of them, the photoaffinity labeled sites were identified as J␣TA28-encoded tryptophan 97 and a residue of the V␤1 segment 46 -51, which contains ␤-Tyr 48 , but not ␤-Tyr 50 (15) . It thus appears that for these TCR, the ABA group was inserted between ␣-Trp 97 (CDR3␣) and ␤-Trp 48 (CDR2␤), rather than two V␤-encoded tyrosines.
Although the interaction of ABA with T1 TCR constituted an important part of T1 TCR-ligand binding, free peptide derivative, even at high concentration (10 M), was unable to photoaffinity-label T1 TCR. 3 However, it has been reported that in other systems hapten in polymeric form or hapten-conjugated peptides at high concentrations can directly bind to TCR, i.e. that some hapten-reactive T cells may have promiscuous MHC restriction (7, 10) . This is reminiscent of antibodies that can strongly bind small organic molecules. As shown by x-ray crystallography, such antibodies utilize residues from different CDR loops (19, 20) . Comparison of the three-dimensional structures of the complexes of fluorescein with a monoclonal antifluorescein antibody and a fluorescein-specific TCR showed that both molecules use very similar principles in binding hapten (19, 41) . Although TCR specific for hapten-modified peptides are unlikely to achieve the high affinities by which antibodies can bind hapten, they may reach higher affinities than TCR specific for conventional peptides, since cells expressing such high affinity TCR are prone to be eliminated by negative selection.
The present study suggests that TCR are able to bind specifically hapten-conjugated peptides by selection of particular V␤ and CDR3␣ sequences. From the data and the model, V␤-encoded residues of CDR1 and mainly CDR2 play a key role in binding the Lys(ABA) side chain; however, residues of CDR3␤ and CDR3␣ spatially and electronically complement these interactions to an integral and sophisticated binding mode (Fig.  7 , Table I ). We suggest that this binding principle has universal aspects, i.e. that TCR expressing selected V␤ and CDR3␣ sequences are able to specifically bind haptens conjugated at the penultimate residue of MHC binding peptides by means of a pocket between CDR2␤ and CDR3␣. As far as is known, and presumably for reasons of chemical reactivity, most "haptenreactive" TCR recognize antigenic peptides containing a hapten-conjugated lysine (5, 11, 12) . The long and flexible nature of the lysine side chain enables haptens to bind in this cavity, in the framework of the canonical diagonal orientation of TCRligand binding.
We and others have previously observed that CTL can also be readily elicited and specifically recognize haptens conjugated in position 4 or 5 of the peptide (11, 13) . In a previous study, we mapped the photoaffinity labeled site(s) for a TCR specific for IASA-YIK(ABA)SAEKI (13) . The labeled site(s) was located in the V␣-encoded C-strand segment 33-39, and computer modeling suggested that the Lys(ABA) side chain inserted into a pocket between the two CDR3 loops (13) . Threedimensional structure analysis showed that TCR indeed have a cavity between the CDR3 loops and that it can accommodate side chains of MHC-bound peptides (21, 22, 24) .
These results provide significant insights into the structural basis of T cell recognition of hapten-conjugated MHC binding peptides. TCR expressing selected V␤ and CDR3␣ sequences can form cavities between CDR loops that can accommodate peptide-conjugated haptens in a highly specific manner (Fig. 7 and Refs. 13 and 15). The structural variability required for this is based mainly on junctional diversity, but V-encoded TCR sequences, in some cases even framework residues, play a role as well. This is consistent with the observation that haptenreactive T cells typically express different TCR sequences than those recognizing the parental epitope (13) (14) (15) .
